Suppr超能文献

(4-取代苯基)-(3-吗啉基丙基)-3-苯基噻唑-2(3)-亚胺衍生物作为抗真菌剂的设计、合成、研究及生物活性评估

Design, Synthesis, Investigation, and Biological Activity Assessments of (4-Substituted-Phenyl)--(3-morpholinopropyl)-3-phenylthiazol-2(3)-imine Derivatives as Antifungal Agents.

作者信息

Haji Ali Sazan, Osmaniye Derya, Sağlık Begüm Nurpelin, Levent Serkan, Özkay Yusuf, Kaplancıklı Zafer Asım

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hawler Medical University, Erbil 44000, Iraq.

Graduate Education Institute, Anadolu University, Eskişehir 26470, Turkey.

出版信息

ACS Omega. 2024 Sep 16;9(38):39326-39343. doi: 10.1021/acsomega.3c07879. eCollection 2024 Sep 24.

Abstract

In this study, a series of novel thiazol-2(3)-imine (-) were designed, synthesized, and characterized by means of H NMR, C NMR, and HRMS spectral analyses. In vitro antifungal activity was performed using a modified EUCAST protocol. Two of the synthesized compounds ( and ) showed activity against and . Compound showed activity against (MIC = 1.23 μg/mL) for 48 h. This value is very similar to ketoconazole. The dynamic analysis of the potential compounds and revealed notable stability while interacting with the 14α-demethylase enzyme substrate. The absorption, distribution, metabolism, and excretion (ADME) studies of the candidate compound showed acceptable ADME parameter data and verified their drug-likeness characteristics. According to the results of this study, compound 4-(4-fluorophenyl)--(3-morpholinopropyl)-3-phenylthiazol-2(3)-imine () and its derivatives as 14α-demethylase inhibitors can be used as a new antifungal for further structural improvements and additional research.

摘要

在本研究中,设计、合成了一系列新型噻唑 - 2(3)-亚胺(-),并通过氢核磁共振(¹H NMR)、碳核磁共振(¹³C NMR)和高分辨质谱(HRMS)光谱分析对其进行了表征。使用改良的欧洲抗菌药物敏感性试验委员会(EUCAST)方案进行体外抗真菌活性检测。所合成的两种化合物( 和 )对 和 显示出活性。化合物 对 (最小抑菌浓度(MIC)= 1.23 μg/mL)在48小时内显示出活性。该值与酮康唑非常相似。对潜在化合物 和 的动力学分析表明,它们在与14α - 脱甲基酶底物相互作用时具有显著的稳定性。候选化合物的吸收、分布、代谢和排泄(ADME)研究显示出可接受的ADME参数数据,并证实了它们的类药特性。根据本研究结果,化合物4 - (4 - 氟苯基)- - (3 - 吗啉丙基)-3 - 苯基噻唑 - 2(3)-亚胺( )及其衍生物作为14α - 脱甲基酶抑制剂可作为新型抗真菌剂用于进一步的结构优化和深入研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b2/11425616/4e739fdfcbe9/ao3c07879_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验